CIK 0001984086 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Septerna, Inc.
Sign in to watch- Ticker
- SEPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843891440
- Phone
- 650-338-3533
- Business address
- 250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,210,085
- in 3 filings, $4.2M under 10b5-1 plans
Net −$4,210,085. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-18 | Klein Uwe SVP, Biological Sciences | Option exercise · Stock Option (Right to Buy) | −4,935 | 9,001 | ||
| 2025-08-18 | Klein Uwe SVP, Biological Sciences | Option exercise · Stock Option (Right to Buy) | −7,621 | 33,027 | ||
| 2025-08-07 | Shaikhly Samira Chief People Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-08-07 | Bhatt Elizabeth President and COO | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2025-08-07 | Kim Jae B. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2025-08-07 | Labrucherie Gil M Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2025-08-07 | Finer Jeffrey Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2025-08-07 | Long Daniel D. SVP, Drug Discovery | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-08-07 | Klein Uwe SVP, Biological Sciences | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-17 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-06-17 | Sharp Shalini Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-06-17 | Tong Jeffrey K Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-06-17 | Coulie Bernard Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-06-17 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-06-17 | Bassan Abraham Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-06-17 | Ezekowitz Alan Director | Grant or award · Stock Option (Right to Buy) | +16,623 | 16,623 | ||
| 2025-04-03 | Finer Jeffrey CEO and President | Option exercise | +5,000 | $2.76 | $14K | 826,907 |
| 2025-04-03 | Finer Jeffrey CEO and President | Option exercise · Stock Option (Right to Buy) | −5,000 | 397,212 | ||
| 2025-04-02 | Finer Jeffrey CEO and President | Option exercise | +50,000 | $2.76 | $138K | 821,907 |
| 2025-04-02 | Finer Jeffrey CEO and President | Option exercise · Stock Option (Right to Buy) | −50,000 | 402,212 |
Page 6 of 8 · 148 trades